Literature DB >> 29365312

Mutational dynamics of early and late relapsed childhood ALL: rapid clonal expansion and long-term dormancy.

Jean-François Spinella1, Chantal Richer1, Pauline Cassart1, Manon Ouimet1, Jasmine Healy1, Daniel Sinnett1,2.   

Abstract

Childhood acute lymphoblastic leukemia (cALL) is the most frequent pediatric cancer. Refractory/relapsed cALL presents a survival rate of ∼45% and is still one of the leading causes of death by disease among children. Mechanisms, such as clonal competition and evolutionary adaptation, govern treatment resistance. However, the underlying clonal dynamics leading to multiple relapses and differentiating early (<36 months postdiagnosis) from late relapse events remain elusive. Here, we use an integrative genome-based analysis combined with serial sampling of relapsed tumors (from primary tumor to ≤4 relapse events) from 19 pre-B-cell cALL patients (8 early and 11 late relapses) to assess the fitness of somatic mutations and infer their ancestral relationships. By quantifying both general clonal dynamics and newly acquired subclonal diversity, we show that 2 distinct evolutionary patterns govern early and late relapse: on one hand, a highly dynamic pattern, sustained by a putative defect of DNA repair processes, illustrating the quick emergence of fitter clones, and on the other hand, a quasi-inert evolution pattern, suggesting the escape from dormancy of leukemia stem cells likely spared from initial cytoreductive therapy. These results offer new insights into cALL relapse mechanisms and highlight the pressing need for adapted treatment strategies to circumvent resistance mechanisms.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2018        PMID: 29365312      PMCID: PMC5812325          DOI: 10.1182/bloodadvances.2017011510

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  46 in total

1.  Clonal stability in late-relapsing childhood lymphoblastic leukaemia.

Authors:  L Frost; A Goodeve; G Wilson; I Peake; H Barker; A Vora
Journal:  Br J Haematol       Date:  1997-09       Impact factor: 6.998

2.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

3.  Origins of "late" relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes.

Authors:  A M Ford; K Fasching; E R Panzer-Grümayer; M Koenig; O A Haas; M F Greaves
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

Review 4.  Genetic Basis of Acute Lymphoblastic Leukemia.

Authors:  Ilaria Iacobucci; Charles G Mullighan
Journal:  J Clin Oncol       Date:  2017-02-13       Impact factor: 44.544

5.  Outcomes for children and adolescents with cancer: challenges for the twenty-first century.

Authors:  Malcolm A Smith; Nita L Seibel; Sean F Altekruse; Lynn A G Ries; Danielle L Melbert; Maura O'Leary; Franklin O Smith; Gregory H Reaman
Journal:  J Clin Oncol       Date:  2010-04-19       Impact factor: 44.544

6.  Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.

Authors:  Ching-Hon Pui; Deqing Pei; Elaine Coustan-Smith; Sima Jeha; Cheng Cheng; W Paul Bowman; John T Sandlund; Raul C Ribeiro; Jeffrey E Rubnitz; Hiroto Inaba; Deepa Bhojwani; Tanja A Gruber; Wing H Leung; James R Downing; William E Evans; Mary V Relling; Dario Campana
Journal:  Lancet Oncol       Date:  2015-03-20       Impact factor: 41.316

7.  A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.

Authors:  Chris Hunter; Raffaella Smith; Daniel P Cahill; Philip Stephens; Claire Stevens; Jon Teague; Chris Greenman; Sarah Edkins; Graham Bignell; Helen Davies; Sarah O'Meara; Adrian Parker; Tim Avis; Syd Barthorpe; Lisa Brackenbury; Gemma Buck; Adam Butler; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Matthew Gorton; Kristian Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jonathon Hinton; Andy Jenkinson; David Jones; Vivienne Kosmidou; Ross Laman; Richard Lugg; Andrew Menzies; Janet Perry; Robert Petty; Keiran Raine; David Richardson; Rebecca Shepherd; Alexandra Small; Helen Solomon; Calli Tofts; Jennifer Varian; Sofie West; Sara Widaa; Andy Yates; Douglas F Easton; Gregory Riggins; Jennifer E Roy; Kymberly K Levine; Wolf Mueller; Tracy T Batchelor; David N Louis; Michael R Stratton; P Andrew Futreal; Richard Wooster
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

8.  Relapse of acute lymphoblastic leukaemia 14 years after presentation: use of molecular techniques to confirm true re-emergence.

Authors:  M Levasseur; Z T Maung; G H Jackson; J Kernahan; S J Proctor; P G Middleton
Journal:  Br J Haematol       Date:  1994-06       Impact factor: 6.998

9.  Late relapsing childhood lymphoblastic leukemia.

Authors:  A Vora; L Frost; A Goodeve; G Wilson; R M Ireland; J Lilleyman; T Eden; I Peake; S Richards
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

Review 10.  Clonal evolution in hematological malignancies and therapeutic implications.

Authors:  D A Landau; S L Carter; G Getz; C J Wu
Journal:  Leukemia       Date:  2013-08-27       Impact factor: 11.528

View more
  12 in total

Review 1.  Prognostic Impact of Somatic Copy Number Alterations in Childhood B-Lineage Acute Lymphoblastic Leukemia.

Authors:  Beatriz Rosales-Rodríguez; Juan Carlos Núñez-Enríquez; Juan Manuel Mejía-Aranguré; Haydeé Rosas-Vargas
Journal:  Curr Oncol Rep       Date:  2020-11-14       Impact factor: 5.075

2.  Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia.

Authors:  Anica M Wandler; Benjamin J Huang; Jeffrey W Craig; Kathryn Hayes; Hannah Yan; Lauren K Meyer; Alessandro Scacchetti; Gabriela Monsalve; Monique Dail; Qing Li; Jasmine C Wong; Olga Weinberg; Robert P Hasserjian; Scott C Kogan; Philip Jonsson; Keith Yamamoto; Deepak Sampath; Joy Nakitandwe; James R Downing; Jinghui Zhang; Jon C Aster; Barry S Taylor; Kevin Shannon
Journal:  Leukemia       Date:  2020-02-17       Impact factor: 11.528

Review 3.  A rare subgroup of leukemia stem cells harbors relapse-inducing potential in acute lymphoblastic leukemia.

Authors:  Daniela Senft; Irmela Jeremias
Journal:  Exp Hematol       Date:  2018-09-24       Impact factor: 3.084

4.  Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia.

Authors:  Esmé Waanders; Zhaohui Gu; Stephanie M Dobson; Željko Antić; Roland P Kuiper; Charles G Mullighan; Jeremy Chase Crawford; Xiaotu Ma; Michael N Edmonson; Debbie Payne-Turner; Maartje van de Vorst; Marjolijn C J Jongmans; Irina McGuire; Xin Zhou; Jian Wang; Lei Shi; Stanley Pounds; Deqing Pei; Cheng Cheng; Guangchun Song; Yiping Fan; Ying Shao; Michael Rusch; Kelly McCastlain; Jiangyan Yu; Ruben van Boxtel; Francis Blokzijl; Ilaria Iacobucci; Kathryn G Roberts; Ji Wen; Gang Wu; Jing Ma; John Easton; Geoffrey Neale; Scott R Olsen; Kim E Nichols; Ching-Hon Pui; Jinghui Zhang; William E Evans; Mary V Relling; Jun J Yang; Paul G Thomas; John E Dick
Journal:  Blood Cancer Discov       Date:  2020-07

5.  Establishment and characterization of a novel childhood acute lymphoblastic leukemia cell line, HXEX-ALL1, with chromosome 9p and 17p deletions.

Authors:  Yiping Zhu; Rong Yang; Ju Gao; Yanle Zhang; Ge Zhang; Ling Gu
Journal:  Cancer Cell Int       Date:  2019-04-29       Impact factor: 5.722

Review 6.  When dormancy fuels tumour relapse.

Authors:  Karla Santos-de-Frutos; Nabil Djouder
Journal:  Commun Biol       Date:  2021-06-16

7.  Mutational patterns and clonal evolution from diagnosis to relapse in pediatric acute lymphoblastic leukemia.

Authors:  Shumaila Sayyab; Anders Lundmark; Malin Larsson; Markus Ringnér; Sara Nystedt; Yanara Marincevic-Zuniga; Katja Pokrovskaja Tamm; Jonas Abrahamsson; Linda Fogelstrand; Mats Heyman; Ulrika Norén-Nyström; Gudmar Lönnerholm; Arja Harila-Saari; Eva C Berglund; Jessica Nordlund; Ann-Christine Syvänen
Journal:  Sci Rep       Date:  2021-08-06       Impact factor: 4.379

8.  [Prognostic significance and risk factors of minimal residual disease ≥1% on 19th day of induction chemotherapy in children with acute lymphoblastic leukemia].

Authors:  Jieming Yu; Tiantian Yi; Guanchuan Lin; Jianyun Wen; Libai Chen; Jiaqi Chen; Xuedong Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-02-29

9.  Single-cell analysis of childhood leukemia reveals a link between developmental states and ribosomal protein expression as a source of intra-individual heterogeneity.

Authors:  Maxime Caron; Pascal St-Onge; Thomas Sontag; Yu Chang Wang; Chantal Richer; Ioannis Ragoussis; Daniel Sinnett; Guillaume Bourque
Journal:  Sci Rep       Date:  2020-05-15       Impact factor: 4.379

10.  PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis.

Authors:  Maria Palmieri; Margherita Baldassarri; Francesca Fava; Alessandra Fabbiani; Giuseppe Maria Campennì; Maria Antonietta Mencarelli; Rossella Tita; Stefania Marsili; Alessandra Renieri; Elisa Frullanti
Journal:  Cancer Cell Int       Date:  2019-10-28       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.